KEGG   DISEASE: Marfan syndrome
Entry
H00653                      Disease                                
Name
Marfan syndrome
  Subgroup
Marfan lipodystrophy syndrome
Description
Marfan syndrome (MFS) is a relatively common autosomal dominant disorder of connective tissue. It affects many parts of the body involving the skeletal, ocular, and cardiovascular systems. Cardiac manifestations are significant contributors to morbidity and mortality. MFS is caused by mutations in the gene for fibrillin-1.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  Multiple developmental anomalies or syndromes
   LD28  Syndromes with connective tissue involvement as a major feature
    H00653  Marfan syndrome
Pathway-based classification of diseases [BR:br08402]
 Signal transduction
  nt06507  TGFB signaling
   H00653  Marfan syndrome
 Cellular process
  nt06539  Cytoskeleton in muscle cells
   H00653  Marfan syndrome
Pathway
hsa04820 Cytoskeleton in muscle cells   
Network
nt06507 TGFB signaling
nt06539 Cytoskeleton in muscle cells
Gene
FBN1 [HSA:2200] [KO:K06825]
Other DBs
ICD-11: LD28.01
ICD-10: Q87.4
MeSH: D008382
OMIM: 154700 616914
Reference
  Authors
Robinson PN, Booms P
  Title
The molecular pathogenesis of the Marfan syndrome.
  Journal
Cell Mol Life Sci 58:1698-707 (2001)
DOI:10.1007/PL00000807
Reference
  Authors
Robinson PN, Arteaga-Solis E, Baldock C, Collod-Beroud G, Booms P, De Paepe A, Dietz HC, Guo G, Handford PA, Judge DP, Kielty CM, Loeys B, Milewicz DM, Ney A, Ramirez F, Reinhardt DP, Tiedemann K, Whiteman P, Godfrey M
  Title
The molecular genetics of Marfan syndrome and related disorders.
  Journal
J Med Genet 43:769-87 (2006)
DOI:10.1136/jmg.2005.039669
Reference
  Authors
Robinson PN, Booms P, Katzke S, Ladewig M, Neumann L, Palz M, Pregla R, Tiecke F, Rosenberg T
  Title
Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies.
  Journal
Hum Mutat 20:153-61 (2002)
DOI:10.1002/humu.10113
Reference
  Authors
Robinson PN, Godfrey M
  Title
The molecular genetics of Marfan syndrome and related microfibrillopathies.
  Journal
J Med Genet 37:9-25 (2000)
DOI:10.1136/jmg.37.1.9
Reference
  Authors
Graul-Neumann LM, Kienitz T, Robinson PN, Baasanjav S, Karow B, Gillessen-Kaesbach G, Fahsold R, Schmidt H, Hoffmann K, Passarge E
  Title
Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-gene.
  Journal
Am J Med Genet A 152A:2749-55 (2010)
DOI:10.1002/ajmg.a.33690
LinkDB

» Japanese version

KEGG   DISEASE: Weill-Marchesani syndrome
Entry
H00673                      Disease                                
Name
Weill-Marchesani syndrome
Description
Weill-Marchesani syndrome (WMS) is a rare connective tissue disorder characterized by short stature, brachydactyly, ectopia lentis and spherophakia. Decreased joint flexibility is one of the features of this syndrome.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  Multiple developmental anomalies or syndromes
   LD21  Syndromes with eye anomalies as a major feature
    H00673  Weill-Marchesani syndrome
Pathway-based classification of diseases [BR:br08402]
 Cellular process
  nt06539  Cytoskeleton in muscle cells
   H00673  Weill-Marchesani syndrome
Pathway
hsa04820 Cytoskeleton in muscle cells   
Network
nt06539 Cytoskeleton in muscle cells
Gene
(WMS1) ADAMTS10 [HSA:81794] [KO:K08625]
(WMS2) FBN1 [HSA:2200] [KO:K06825]
(WMS3) LTBP2 [HSA:4053] [KO:K08023]
(WMS4) ADAMTS17 [HSA:170691] [KO:K08631]
Other DBs
ICD-11: LD21.Y
ICD-10: Q87.1
MeSH: D056846
OMIM: 277600 608328 614819 613195
Reference
  Authors
Faivre L, Dollfus H, Lyonnet S, Alembik Y, Megarbane A, Samples J, Gorlin RJ, Alswaid A, Feingold J, Le Merrer M, Munnich A, Cormier-Daire V
  Title
Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome.
  Journal
Am J Med Genet A 123A:204-7 (2003)
DOI:10.1002/ajmg.a.20289
Reference
  Authors
Tsilou E, MacDonald IM
  Title
Weill-Marchesani Syndrome
  Journal
GeneReviews (1993)
Reference
PMID:19836009 (WMS1_4)
  Authors
Morales J, Al-Sharif L, Khalil DS, Shinwari JM, Bavi P, Al-Mahrouqi RA, Al-Rajhi A, Alkuraya FS, Meyer BF, Al Tassan N
  Title
Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature.
  Journal
Am J Hum Genet 85:558-68 (2009)
DOI:10.1016/j.ajhg.2009.09.011
Reference
PMID:12525539 (WMS2)
  Authors
Faivre L, Gorlin RJ, Wirtz MK, Godfrey M, Dagoneau N, Samples JR, Le Merrer M, Collod-Beroud G, Boileau C, Munnich A, Cormier-Daire V
  Title
In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome.
  Journal
J Med Genet 40:34-6 (2003)
DOI:10.1136/jmg.40.1.34
Reference
PMID:22539340 (WMS3)
  Authors
Haji-Seyed-Javadi R, Jelodari-Mamaghani S, Paylakhi SH, Yazdani S, Nilforushan N, Fan JB, Klotzle B, Mahmoudi MJ, Ebrahimian MJ, Chelich N, Taghiabadi E, Kamyab K, Boileau C, Paisan-Ruiz C, Ronaghi M, Elahi E
  Title
LTBP2 mutations cause Weill-Marchesani and Weill-Marchesani-like syndrome and affect disruptions in the extracellular matrix.
  Journal
Hum Mutat 33:1182-7 (2012)
DOI:10.1002/humu.22105
LinkDB

» Japanese version

KEGG   DISEASE: Stiff skin syndrome
Entry
H01173                      Disease                                
Name
Stiff skin syndrome
Description
Stiff skin syndrome (SSS) is an autosomal dominant congenital form of scleroderma characterized by stony-hard skin, limitation of joint mobility, and mild hypertrichosis, remarkable in the areas with abundant fascia on the thighs and buttocks. SSS is caused by mutations in the Arg-Gly-Asp (RGD) sequence-encoding domain of fibrillin-1 that mediates integrin binding.
Category
Skin disease
Brite
Human diseases in ICD-11 classification [BR:br08403]
 14 Diseases of the skin
  Skin disorders involving specific cutaneous structures
   Disorders of the dermis and subcutis
    Disorders of cutaneous connective tissue
     Fibromatoses and keloids
      EE6Y  Other specified fibromatous disorders of skin and soft tissue
       H01173  Stiff skin syndrome
Pathway-based classification of diseases [BR:br08402]
 Cellular process
  nt06539  Cytoskeleton in muscle cells
   H01173  Stiff skin syndrome
Pathway
hsa04820  Cytoskeleton in muscle cells
hsa04350  TGF-beta signaling pathway
Network
nt06539 Cytoskeleton in muscle cells
Gene
FBN1 [HSA:2200] [KO:K06825]
Other DBs
ICD-11: EE6Y
MeSH: C566112
OMIM: 184900
Reference
  Authors
Liu T, McCalmont TH, Frieden IJ, Williams ML, Connolly MK, Gilliam AE
  Title
The stiff skin syndrome: case series, differential diagnosis of the stiff skin phenotype, and review of the literature.
  Journal
Arch Dermatol 144:1351-9 (2008)
DOI:10.1001/archderm.144.10.1351
Reference
  Authors
Geng S, Lei X, Toyohara JP, Zhan P, Wang J, Tan S
  Title
Stiff skin syndrome.
  Journal
J Eur Acad Dermatol Venereol 20:729-32 (2006)
DOI:10.1111/j.1468-3083.2006.01619.x
Reference
  Authors
Loeys BL, Gerber EE, Riegert-Johnson D, Iqbal S, Whiteman P, McConnell V, Chillakuri CR, Macaya D, Coucke PJ, De Paepe A, Judge DP, Wigley F, Davis EC, Mardon HJ, Handford P, Keene DR, Sakai LY, Dietz HC
  Title
Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome.
  Journal
Sci Transl Med 2:23ra20 (2010)
DOI:10.1126/scitranslmed.3000488
LinkDB

» Japanese version

KEGG   DISEASE: Geleophysic dysplasia
Entry
H00900                      Disease                                
Name
Geleophysic dysplasia
Description
Geleophysic dysplasia (GPHYSD) is an autosomal recessive disorder resembling a lysosomal storage disorder. It is characterized by short stature, short hands and feet due to short, plump tubular bones, stiff joints, distinctive facial features, and progressive valvular cardiac disease.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  Multiple developmental anomalies or syndromes
   LD24  Syndromes with skeletal anomalies as a major feature
    H00900  Geleophysic dysplasia
Pathway-based classification of diseases [BR:br08402]
 Signal transduction
  nt06507  TGFB signaling
   H00900  Geleophysic dysplasia
 Cellular process
  nt06539  Cytoskeleton in muscle cells
   H00900  Geleophysic dysplasia
Pathway
hsa04350  TGF-beta signaling pathway
hsa04820  Cytoskeleton in muscle cells
Network
nt06507 TGFB signaling
nt06539 Cytoskeleton in muscle cells
Gene
(GPHYSD1) ADAMTSL2 [HSA:9719] [KO:K24430]
(GPHYSD2) FBN1 [HSA:2200] [KO:K06825]
(GPHYSD3) LTBP3 [HSA:4054] [KO:K08023]
Other DBs
ICD-11: LD24.8Y
ICD-10: Q87.1
MeSH: C535662
OMIM: 231050 614185 617809
Reference
PMID:6507495
  Authors
Spranger J, Gilbert EF, Arya S, Hoganson GM, Opitz JM
  Title
Geleophysic dysplasia.
  Journal
Am J Med Genet 19:487-99 (1984)
DOI:10.1002/ajmg.1320190310
Reference
PMID:21415077 (ADAMTSL2)
  Authors
Allali S, Le Goff C, Pressac-Diebold I, Pfennig G, Mahaut C, Dagoneau N, Alanay Y, Brady AF, Crow YJ, Devriendt K, Drouin-Garraud V, Flori E, Genevieve D, Hennekam RC, Hurst J, Krakow D, Le Merrer M, Lichtenbelt KD, Lynch SA, Lyonnet S, MacDermot K, Mansour S, Megarbane A, Santos HG, Splitt M, Superti-Furga A, Unger S, Williams D, Munnich A, Cormier-Daire V
  Title
Molecular screening of ADAMTSL2 gene in 33 patients reveals the genetic heterogeneity of geleophysic dysplasia.
  Journal
J Med Genet 48:417-21 (2011)
DOI:10.1136/jmg.2010.087544
Reference
PMID:21683322 (FBN1)
  Authors
Le Goff C, Mahaut C, Wang LW, Allali S, Abhyankar A, Jensen S, Zylberberg L, Collod-Beroud G, Bonnet D, Alanay Y, Brady AF, Cordier MP, Devriendt K, Genevieve D, Kiper PO, Kitoh H, Krakow D, Lynch SA, Le Merrer M, Megarbane A, Mortier G, Odent S, Polak M, Rohrbach M, Sillence D, Stolte-Dijkstra I, Superti-Furga A, Rimoin DL, Topouchian V, Unger S, Zabel B, Bole-Feysot C, Nitschke P, Handford P, Casanova JL, Boileau C, Apte SS, Munnich A, Cormier-Daire V
  Title
Mutations in the TGFbeta binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias.
  Journal
Am J Hum Genet 89:7-14 (2011)
DOI:10.1016/j.ajhg.2011.05.012
Reference
PMID:27068007 (LTBP3)
  Authors
McInerney-Leo AM, Le Goff C, Leo PJ, Kenna TJ, Keith P, Harris JE, Steer R, Bole-Feysot C, Nitschke P, Kielty C, Brown MA, Zankl A, Duncan EL, Cormier-Daire V
  Title
Mutations in LTBP3 cause acromicric dysplasia and geleophysic dysplasia.
  Journal
J Med Genet 53:457-64 (2016)
DOI:10.1136/jmedgenet-2015-103647
LinkDB

» Japanese version

KEGG   DISEASE: Acromicric dysplasia
Entry
H02228                      Disease                                
Name
Acromicric dysplasia
Description
Acromicric dysplasia (ACMICD) is a rare autosomal dominant bone dysplasia characterised by severe short stature, short hands and feet, joint limitations, skin thickening, and distinct facial features. It has been reported that mutations in FBN1 are responsible for this disease.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  Multiple developmental anomalies or syndromes
   LD24  Syndromes with skeletal anomalies as a major feature
    H02228  Acromicric dysplasia
Pathway-based classification of diseases [BR:br08402]
 Cellular process
  nt06539  Cytoskeleton in muscle cells
   H02228  Acromicric dysplasia
Pathway
hsa04820 Cytoskeleton in muscle cells   
Network
nt06539 Cytoskeleton in muscle cells
Gene
FBN1 [HSA:2200] [KO:K06825]
Other DBs
ICD-11: LD24.8Y
ICD-10: Q77.8
MeSH: C535662
OMIM: 102370
Reference
  Authors
Faivre L, Le Merrer M, Baumann C, Polak M, Chatelain P, Sulmont V, Cousin J, Bost M, Cordier MP, Zackai E, Russell K, Finidori G, Pouliquen JC, Munnich A, Maroteaux P, Cormier-Daire V
  Title
Acromicric dysplasia: long term outcome and evidence of autosomal dominant inheritance.
  Journal
J Med Genet 38:745-9 (2001)
DOI:10.1136/jmg.38.11.745
Reference
  Authors
Le Goff C, Mahaut C, Wang LW, Allali S, Abhyankar A, Jensen S, Zylberberg L, Collod-Beroud G, Bonnet D, Alanay Y, Brady AF, Cordier MP, Devriendt K, Genevieve D, Kiper PO, Kitoh H, Krakow D, Lynch SA, Le Merrer M, Megarbane A, Mortier G, Odent S, Polak M, Rohrbach M, Sillence D, Stolte-Dijkstra I, Superti-Furga A, Rimoin DL, Topouchian V, Unger S, Zabel B, Bole-Feysot C, Nitschke P, Handford P, Casanova JL, Boileau C, Apte SS, Munnich A, Cormier-Daire V
  Title
Mutations in the TGFbeta binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias.
  Journal
Am J Hum Genet 89:7-14 (2011)
DOI:10.1016/j.ajhg.2011.05.012
LinkDB

» Japanese version

DBGET integrated database retrieval system